Tag Archives: Natalie Eaton-Fitch

Research review: Biomarkers for ME/CFS

Posted on 05/25/2023 by wames

Biomarkers for ME/CFS: a systematic review   Australian researchers found 101 key studies in ME/CFS that varied in efficacy, quality, and potential to be developed into a diagnostic biomarker. Most were blood-based and measured a range of dysfunction. “Many of … Continue reading →

Posted in News | Tagged , , , , , , | Comments Off on Research review: Biomarkers for ME/CFS

Research: fMRI reveals differences between ME/CFS diagnostic criteria

Posted on 11/18/2022 by wames

fMRI distinguishes between two classes of ME/CFS   Australian researchers have discovered that patients diagnosed using 2 different criteria, International Consensus Criteria (ICC) and the Fukuda criteria, have different brain activity. The main difference between the 2 criteria is that … Continue reading →

Posted in News | Tagged , , , , , , , , , , | Comments Off on Research: fMRI reveals differences between ME/CFS diagnostic criteria

Understanding ME (and Long COVID)

Posted on 09/12/2022 by wames

Understanding Myalgic Encephalomyelitis – Myalgic Encephalomyelitis and Long COVID have overlapping presentation   Dr Sonya Marshall-Gradisnik and Dr Natalie Eaton-Fitch from Griffith University, on the Gold Coast in Australia, say there is a significant overlap in symptoms and possibly the … Continue reading →

Posted in News | Tagged , , , | Comments Off on Understanding ME (and Long COVID)

Research: Impaired TRPM3 ion channel function found in ME/CFS & Long COVID

Posted on 08/20/2022 by wames

TRPM3 dysfunction in post COVID-19 condition and ME/CFS patients   Research from the NCNED in Australia, using their Electrophysiology ‘Patch Clamp’ technique, concludes: The results of this investigation suggest that post COVID-19 condition patients may have impaired TRPM3 ion channel … Continue reading →

Posted in News | Tagged , , , , , , , , , , | Comments Off on Research: Impaired TRPM3 ion channel function found in ME/CFS & Long COVID

Treatment research: …restoration using Naltrexone in natural killer cells of ME/CFS patients

Posted on 02/23/2022 by wames

Impaired TRPM3-dependent calcium influx and restoration using Naltrexone in natural killer cells of myalgic encephalomyelitis/chronic fatigue syndrome patients, by Natalie Eaton-Fitch, Stanley Du Preez, Hélène Cabanas, Katsuhiko Muraki, Donald Staines & Sonya Marshall-Gradisnik in Journal of Translational Medicine volume 20, … Continue reading →

Posted in News | Tagged , , , , , , , , , | Comments Off on Treatment research: …restoration using Naltrexone in natural killer cells of ME/CFS patients

Research: The characterization of IL-2 stimulation & treatment of TRPM3… in ME/CFS

Posted on 11/15/2021 by wames

Characterization of IL-2 stimulation and TRPM7 pharmacomodulation in NK Cell cytotoxicity and channel Co-Localization with PIP2 in Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome patients, by Stanley Du Preez , Natalie Eaton-Fitch, Helene Cabanas, Donald Staines and Sonya Marshall-Gradisnik in Int. J. … Continue reading →

Posted in News | Tagged , , , , , , , , , , | Comments Off on Research: The characterization of IL-2 stimulation & treatment of TRPM3… in ME/CFS

Research: Impact of life stressors on ME/CFS symptoms

Posted on 10/27/2021 by wames

Impact of life stressors on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome symptoms: An Australian longitudinal study, by  Cassandra Balinas, Natalie Eaton-Fitch, Rebekah Maksoud, Donald Staines, and Sonya Marshall-Gradisnik in Int. J. Environ. Res. Public Health 2021, 18(20) [10.3390/ijerph182010614] (This article belongs to the … Continue reading →

Posted in News | Tagged , , , , , , | Comments Off on Research: Impact of life stressors on ME/CFS symptoms

Research: Potential therapeutic benefit of Low Dose Naltrexone in ME/CFS

Posted on 07/16/2021 by wames

Potential Therapeutic Benefit of Low Dose Naltrexone in Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome: role of Transient Receptor Potential Melastatin 3 Ion channels in pathophysiology and treatment, by Helene Cabanas,  Katsuhiko Muraki,  Natalie Eaton-Fitch,  Donald Ross Staines and Sonya Marshall-Gradisnik in … Continue reading →

Posted in News | Tagged , , , , , , , , , , | Comments Off on Research: Potential therapeutic benefit of Low Dose Naltrexone in ME/CFS

Systematic review of sleep characteristics in ME/CFS

Posted on 06/15/2021 by wames

Systematic review of sleep characteristics in Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome, by  Rebekah Maksoud, Natalie Eaton-Fitch, Michael Matula, Hélène Cabanas, Donald Staines and Sonya Marshall-Gradisnik in Healthcare 2021, 9(5), 568; 11 May 2021  [doi.org/10.3390/healthcare9050568] (This article belongs to the Special Issue ME/CFS … Continue reading →

Posted in News | Tagged , , , , , , , , | Comments Off on Systematic review of sleep characteristics in ME/CFS

A systematic review of mitochondrial abnormalities in ME/CFS/SEID

Posted on 08/16/2020 by wames

A systematic review of mitochondrial abnormalities in myalgic encephalomyelitis/chronic fatigue syndrome/systemic exertion intolerance disease, by Sean Holden, Rebekah  Maksoud, Natalie Eaton-Fitch, Hélène Cabanas, Donald Staines & Sonya Marshall-Gradisnik in Journal of Translational Medicine vol 18, no: 290 (2020)[doi.org/10.1186/s12967-020-02452-3]   Review … Continue reading →

Posted in News | Tagged , , , , , , , | Comments Off on A systematic review of mitochondrial abnormalities in ME/CFS/SEID